Neuromuscular Paralysis is not a Barrier to Same Day Catheter Removal After HoLEP.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
01 2023
Historique:
received: 27 07 2022
revised: 24 10 2022
accepted: 24 10 2022
pubmed: 19 11 2022
medline: 11 1 2023
entrez: 18 11 2022
Statut: ppublish

Résumé

To determine if same day catheter removal is feasible in a population of holmium laser enucleation of the prostate patients who received paralysis and if bladder pressure monitoring could predict successful catheter removal. From February 2021 to February 2022, we evaluated same day catheter removal for patients undergoing holmium laser enucleation of the prostate. Criteria for proceeding with same day catheter removal included: an uncomplicated procedure, continuous bladder irrigation weaned within 120 minutes of arrival to PACU, minimal postoperative hematuria and a bladder pressure over 30 cmH One hundred and eight patients were enrolled, with a median age of 68 years (IQR: 62.0-73.0) and prostate volume 80.8cc (IQR: 64.8-112.3). Criteria for catheter removal was met by 83/108 (76.9%) patients. Of those that attempted a trial of void, 69/83 passed for an effective pass rate of 83.1%. Median maximum detrusor pressure for those that passed and failed were 51.0 cmH Same day catheter removal is feasible in those who receive neuromuscular paralysis, with a success rate >80%. Bladder pressure monitoring did not assist with differentiating which patients will pass or fail a trial of void. Intraoperative Lasix administration may be helpful in increasing success for same day catheter removal while elevated preoperative PVR was associated with TOV failure.

Identifiants

pubmed: 36400271
pii: S0090-4295(22)00941-4
doi: 10.1016/j.urology.2022.10.020
pii:
doi:

Substances chimiques

Furosemide 7LXU5N7ZO5
Holmium W1XX32SQN1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

179-183

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Gopal Narang (G)

Department of Urology, University of North Carolina Chapel Hill, Chapel Hill, NC. Electronic address: GopiNarang@gmail.com.

Charlotte Pougnier (C)

Department of Urology, Mayo Clinic Rochester, Rochester, MN.

Kevin Wymer (K)

Department of Urology, Mayo Clinic Arizona, Phoenix, AZ.

Alexandra Chavez (A)

Mayo Clinic Alix School of Medicine, Phoenix, AZ.

Lanyu Mi (L)

Department of Quantitative Health Science Mayo Clinic Scottsdale, Phoenix, AZ.

Mitchell Humphreys (M)

Department of Urology, Mayo Clinic Arizona, Phoenix, AZ.

Scott Cheney (S)

Department of Urology, Mayo Clinic Arizona, Phoenix, AZ.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH